|
|
||||||||
J Thorac Cardiovasc Surg 2009;138:491-492
© 2009 The American Association for Thoracic Surgery
Brief Clinical Report |
a Mayo Clinic Rochester Department of Pharmacy, Rochester, Minn
b Department of Anesthesiology, Division of Cardiovascular Anesthesiology, Mayo Clinic Rochester, Rochester, Minn
c Department of Cardiac Surgery, Division of Cardiovascular Surgery, Mayo Clinic Rochester, Rochester, Minn
d Department of Anesthesiology, Division of Cardiovascular Anesthesiology, Mayo Clinic Rochester, Rochester, Minn
Received for publication February 13, 2008; revisions received May 22, 2008; accepted for publication June 15, 2008. * Address for reprints: William J. Mauermann, MD, 200 First St SW–Mb 2-752, Rochester, MN 55909. (Email: mauermann.william@mayo.edu).
| The first 20% of the full text of this article appears below. |
| Introduction |
|---|
| Clinical Summary |
|---|
Within 3 hours of discontinuing the vasopressin infusion, the patient's urine output increased to more than 1 L/h without any other medication changes, and oral fluid intake averaged 300 mL/h (Figure 1
). Specifically, no diuretics had been administered for at least 24 hours. The serum sodium concentration (normal range, 135–145 mmol/L) increased to 135 mmol/L from 129
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |